Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum
Feto-maternal microchimerism (FMM) involves bidirectional cross-placental trafficking during pregnancy, leading to a micro-chimeric state that can persist for decades. In this manner a pregnant woman will harbor cells from her mother, as well as, cells from her child. Historically, eclampsia, a seve...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00659/full |
id |
doaj-d5bbbec1214b4281bb84415cb6e2220f |
---|---|
record_format |
Article |
spelling |
doaj-d5bbbec1214b4281bb84415cb6e2220f2020-11-25T01:29:06ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-03-011010.3389/fimmu.2019.00659444055Feto-Maternal Microchimerism: The Pre-eclampsia ConundrumSinuhe Hahn0Paul Hasler1Lenka Vokalova2Shane Vontelin van Breda3Shane Vontelin van Breda4Nandor Gabor Than5Irene Mathilde Hoesli6Olav Lapaire7Simona W. Rossi8Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandDivision of Rheumatology, Medical University Department, Kantonsspital Aarau, Aarau, SwitzerlandDepartment of Biomedicine, University Hospital Basel, Basel, SwitzerlandDepartment of Biomedicine, University Hospital Basel, Basel, SwitzerlandDivision of Rheumatology, Medical University Department, Kantonsspital Aarau, Aarau, SwitzerlandSystems Biology of Reproduction Lendulet Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, HungaryDepartment of Obstetrics, University Women's Hospital Basel, Basel, SwitzerlandDepartment of Obstetrics, University Women's Hospital Basel, Basel, SwitzerlandDepartment of Biomedicine, University Hospital Basel, Basel, SwitzerlandFeto-maternal microchimerism (FMM) involves bidirectional cross-placental trafficking during pregnancy, leading to a micro-chimeric state that can persist for decades. In this manner a pregnant woman will harbor cells from her mother, as well as, cells from her child. Historically, eclampsia, a severe disorder of pregnancy provided the basis for FMM following the detection of trophoblast cells in the lungs of deceased women. Bi-directional cell trafficking between mother and fetus is also altered in pre-eclampsia and has been suggested to contribute to the underlying etiology. FMM has been implicated in tolerance promotion, remission of auto-inflammatory disorders during pregnancy, or the development of autoimmune conditions post-partum. The underlying mechanism whereby the host immune system is modulated is unclear but appears to involve HLA class II molecules, in that incompatibility between mother and fetus promotes remission of rheumatoid arthritis, whereas feto-maternal HLA compatibility may assist in the post-partum initiation of scleroderma. Couples having a high degree of HLA class II compatibility have an increased risk for pre-eclampsia, while the occurrence of scleroderma and rheumatoid arthritis is greater in pre-eclamptic cases than in women with normal pregnancies, suggesting a long term autoimmune predisposition. Since pregnant women with pre-eclampsia exhibit significantly lower levels of maternally-derived micro-chimerism, the question arises whether pre-eclampsia and post-partum development of autoimmune conditions occur due to the failure of the grandmothers cells to adequately regulate an inappropriate micro-chimeric constellation.https://www.frontiersin.org/article/10.3389/fimmu.2019.00659/fullfeto-maternal microchimerismpre-eclampsianon-inherited-maternal-antigenscell-free DNAautoimmunity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sinuhe Hahn Paul Hasler Lenka Vokalova Shane Vontelin van Breda Shane Vontelin van Breda Nandor Gabor Than Irene Mathilde Hoesli Olav Lapaire Simona W. Rossi |
spellingShingle |
Sinuhe Hahn Paul Hasler Lenka Vokalova Shane Vontelin van Breda Shane Vontelin van Breda Nandor Gabor Than Irene Mathilde Hoesli Olav Lapaire Simona W. Rossi Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum Frontiers in Immunology feto-maternal microchimerism pre-eclampsia non-inherited-maternal-antigens cell-free DNA autoimmunity |
author_facet |
Sinuhe Hahn Paul Hasler Lenka Vokalova Shane Vontelin van Breda Shane Vontelin van Breda Nandor Gabor Than Irene Mathilde Hoesli Olav Lapaire Simona W. Rossi |
author_sort |
Sinuhe Hahn |
title |
Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum |
title_short |
Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum |
title_full |
Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum |
title_fullStr |
Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum |
title_full_unstemmed |
Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum |
title_sort |
feto-maternal microchimerism: the pre-eclampsia conundrum |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2019-03-01 |
description |
Feto-maternal microchimerism (FMM) involves bidirectional cross-placental trafficking during pregnancy, leading to a micro-chimeric state that can persist for decades. In this manner a pregnant woman will harbor cells from her mother, as well as, cells from her child. Historically, eclampsia, a severe disorder of pregnancy provided the basis for FMM following the detection of trophoblast cells in the lungs of deceased women. Bi-directional cell trafficking between mother and fetus is also altered in pre-eclampsia and has been suggested to contribute to the underlying etiology. FMM has been implicated in tolerance promotion, remission of auto-inflammatory disorders during pregnancy, or the development of autoimmune conditions post-partum. The underlying mechanism whereby the host immune system is modulated is unclear but appears to involve HLA class II molecules, in that incompatibility between mother and fetus promotes remission of rheumatoid arthritis, whereas feto-maternal HLA compatibility may assist in the post-partum initiation of scleroderma. Couples having a high degree of HLA class II compatibility have an increased risk for pre-eclampsia, while the occurrence of scleroderma and rheumatoid arthritis is greater in pre-eclamptic cases than in women with normal pregnancies, suggesting a long term autoimmune predisposition. Since pregnant women with pre-eclampsia exhibit significantly lower levels of maternally-derived micro-chimerism, the question arises whether pre-eclampsia and post-partum development of autoimmune conditions occur due to the failure of the grandmothers cells to adequately regulate an inappropriate micro-chimeric constellation. |
topic |
feto-maternal microchimerism pre-eclampsia non-inherited-maternal-antigens cell-free DNA autoimmunity |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2019.00659/full |
work_keys_str_mv |
AT sinuhehahn fetomaternalmicrochimerismthepreeclampsiaconundrum AT paulhasler fetomaternalmicrochimerismthepreeclampsiaconundrum AT lenkavokalova fetomaternalmicrochimerismthepreeclampsiaconundrum AT shanevontelinvanbreda fetomaternalmicrochimerismthepreeclampsiaconundrum AT shanevontelinvanbreda fetomaternalmicrochimerismthepreeclampsiaconundrum AT nandorgaborthan fetomaternalmicrochimerismthepreeclampsiaconundrum AT irenemathildehoesli fetomaternalmicrochimerismthepreeclampsiaconundrum AT olavlapaire fetomaternalmicrochimerismthepreeclampsiaconundrum AT simonawrossi fetomaternalmicrochimerismthepreeclampsiaconundrum |
_version_ |
1725098629629214720 |